InsiderClue
Insiders · Profile

Sonsini Peter W.

10% owner at Trevi Therapeutics · 10% owner at Monte Rosa Therapeutics · 10% owner at Marker Therapeutics · and 5 more. Filing since 13 Jan 2016. CIK 0001559807

TRVI Trevi Therapeutics, Inc. 10% owner · 4 trades GLUE Monte Rosa Therapeutics, Inc. 10% owner · 1 trade MRKR Marker Therapeutics, Inc. 10% owner · 1 trade NKTX Nkarta, Inc. 10% owner · 1 trade MIRM Mirum Pharmaceuticals, Inc. 10% owner · 1 trade ORKA Oruka Therapeutics, Inc. 10% owner · 1 trade APPN APPIAN CORP 10% owner · 2 trades ARDX ARDELYX, INC. 10% owner · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TRVI Trevi Therapeutics, Inc.
11 Apr 2022
10% owner
Bought
3,580,526
$6.80M
52.3%
TRVI Trevi Therapeutics, Inc.
18 Oct 2021
10% owner
Bought
1,851,852
no price
31.2%
GLUE Monte Rosa Therapeutics, Inc.
28 Jun 2021
10% owner
Bought
1,050,000
$19.95M
15.8%
MRKR Marker Therapeutics, Inc.
16 Mar 2021
10% owner
Bought
5,714,285
$10.00M
114%
NKTX Nkarta, Inc.
14 Jul 2020
10% owner
Bought
666,666
$12.00M
29.8%
TRVI Trevi Therapeutics, Inc.
3 Apr 2020
10% owner
Sold, plan not stated
564
$1.50K
0.0%
MIRM Mirum Pharmaceuticals, Inc.
22 Jul 2019
10% owner
Bought
450,000
$6.75M
12.0%
TRVI Trevi Therapeutics, Inc.
9 May 2019
10% owner
Bought
2,500,000
$25.00M
129%
ORKA Oruka Therapeutics, Inc.
26 Feb 2018
10% owner
Sold, plan not stated
1,460,209
$731.27K
100%
APPN APPIAN CORP
27 Nov 2017
10% owner
Sold, plan not stated
569,620
$11.10M
100%
APPN APPIAN CORP
20 Nov 2017
10% owner
Sold, plan not stated
2,820,516
$54.97M
100%
ARDX ARDELYX, INC.
18 Jul 2016
10% owner
Bought
763,651
$6.67M
40.2%
ARDX ARDELYX, INC.
18 Jul 2016
10% owner
Bought
763,650
$6.67M
40.2%
ARDX ARDELYX, INC.
13 Jan 2016
10% owner
Bought
500,000
$5.00M
35.7%
ARDX ARDELYX, INC.
13 Jan 2016
10% owner
Bought
500,000
$5.00M
35.7%
15 decisions on file.